The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multi-spatial whole-lesion molecular heterogeneity of an immunotherapy-resistant metastatic melanoma.
 
Akash Mitra
No Relationships to Disclose
 
Whijae Roh
No Relationships to Disclose
 
Alexandre Reuben
No Relationships to Disclose
 
Mariana Macedo
No Relationships to Disclose
 
Fernando Cintra Lopes Carapeto
No Relationships to Disclose
 
Curtis Gumbs
No Relationships to Disclose
 
Jianhua Zhang
No Relationships to Disclose
 
Scott Eric Woodman
No Relationships to Disclose
 
Patrick Hwu
Stock and Other Ownership Interests - Immatics; Iovance Biotherapeutics
Consulting or Advisory Role - Dragonfly Therapeutics; GlaxoSmithKline; Immatics; Iovance Biotherapeutics; Sanofi
Research Funding - Genentech (Inst)
 
Wen-Jen Hwu
Consulting or Advisory Role - Merck
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; MedImmune; Merck/Schering Plough
 
Alexander J. Lazar
Employment - GE Healthcare (I)
Leadership - Archer; Beta Cat Pharmaceuticals
Stock and Other Ownership Interests - Archer; Beta Cat Pharmaceuticals
Honoraria - Bristol-Myers Squibb; Genentech/Roche; Janssen Oncology; Novartis
Consulting or Advisory Role - GE Healthcare; Illumina; Novartis
Research Funding - AstraZeneca; MedImmune; Novartis; Roche
Patents, Royalties, Other Intellectual Property - Elsevier
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis
 
Jennifer Ann Wargo
Leadership - Microbiome DX
Honoraria - Bristol-Myers Squibb; Dava Oncology; Genentech; GlaxoSmithKline; Illumina; Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; Dava Oncology; Genentech; GlaxoSmithKline; Illumina; Novartis
Speakers' Bureau - Genentech; Novartis
Research Funding - Bristol-Myers Squibb (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Patent submitted regarding the role of the microbiome in response to immune checkpoint blockade
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Dava Oncology; Genentech; GlaxoSmithKline; Illumina; Novartis
 
Phillip Andrew Futreal
Consulting or Advisory Role - GenePlus